| News

Healthtech sector growing rapidly in the Basel Area

28.04.2020

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Annual report 2019

Last year, the Basel Area proved to be a location with a promising future. Basel Area Business & Innovation, the investment and innovation promotion agency, has supported the settlement of 30 companies in the cantons of Basel-Stadt, Basel-Landschaft and Jura. The agency’s 2019 annual report further reveals that it also supported the founding of 62 startups.

Despite the fact that, in comparison with the prior year, the number of companies settling in the area decreased by three and the number of startups by ten, the healthtech sector has defied this development to record growth. Seven out of the newly settled companies and six of those newly established are active in this area and develop health technologies, for example for personalized medicine and digitization within the industry.

The media release states that Switzerland Innovation Park Basel Area, which is operated by Basel Area Business & Innovation, enjoyed a “highly successful” year in 2019. As such, the number of companies located there increased from 13 to 32. Further successful developments include the start of construction on the new GRID Campus of Collaboration building at the main site in Allschwil BL, the inauguration of the Jura site in Courroux and the first steps toward the new site on the Novartis Campus in Basel.

Christof Klöpper, CEO of Basel Area Business & Innovation, is quoted in the press release, saying: “In order to position the Basel Area as an attractive location for the settlement of foreign companies and the founding of local startups, as well as to hold our ground in an environment where competition between locations is increasing, a strong positioning is extremely important.” For this reason, a change of name from BaselArea.swiss to Basel Area Business & Innovation was resolved. This is accompanied by a new online presence, the new slogan “More to discover” and a new logo. This logo may also be used by institutions and organizations “so that they can raise the awareness of the economic region at home and abroad and invite companies and talents to discover the potential of the Basel Area.”

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Yokogawa establishes innovation center in Allschwil

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel gains new biotech in Bright Peak

Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.

Read More
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Robots from Basel set to revolutionize surgery

The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.

Read More
Basel Area Business & Innovation, Innovation

T3 Pharma raises over 25 million Swiss francs

T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.

Read More
Basel Area Business & Innovation, Innovation

Versameb raises 6 million Swiss francs

The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.

Read More
Basel Area Business & Innovation, Innovation

Genedata accelerating drug development

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Read More
1 2 3 32

Do you have a question? We'd like to hear from you.